Abstract
Objective
To determine the prognostic value of pT3 bladder urothelial carcinoma substaging in patients without lymphatic involvement.
Patients and methods
Pathologic and clinical data were reviewed on patients who underwent radical cystectomy for urothelial carcinoma between 1991 and 2010. Of the 460 reviewed patients, 74 patients were diagnosed with pathologic T3No urothelial carcinoma of the bladder. The impact of pathologic substaging (pT3a vs. pT3b) was examined to determine the effect on overall and disease-specific survival.
Results
Five years disease-specific and overall survival rates were 46.9 % and 39.6 % for patients with pT3aNo tumor, whereas these ratios were 34.4 and 30.3 %, respectively, for patients with pT3bNo tumor (p > 0.05). Mean disease-specific survival time was 43.94 ± 6.50 months for pT3aNo, while it was 39.01 ± 7.19 months for pT3bNo (p = 0.539). In multivariate cox regression analysis, age (p = 0.459), gender (p = 0.710), urinary diversion type (p = 0.088), and pT3 substaging (p = 0.554) were not noticed as an independent predictive factor for survival.
Conclusion
Macroscopic extravesical extension (pT3b) is not associated with a worse outcome than pT3a disease in lymph node-negative cases of bladder urothelial carcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19:666–675
Lerner SP, Skinner E, Skinner DG (1992) Radical cystectomy in regionally advanced bladder cancer. Urol Clin North Am 19:713–723
Resorlu B, Beduk Y, Baltaci S et al (2008) The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 103:480–483
Girgin C, Sezer A, Delibas M et al (2007) Impact of the level of muscle invasion in organ-confined bladder cancer. Urol Int 78:145–149
Fleming ID, Cooper JS, Henson DE (1997) American Joint Committee on cancer, cancer staging manual, 5th edn. Lippincott-Raven, Philadelphia, pp 241–243
Bastian PJ, Hutterer GC, Shariat SF et al (2008) Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. BJU Int 101:450–454
Boudreaux KJ Jr, Chang SS, Lowrance WT et al (2009) Comparison of American Join Committee on cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer 115:770–774
Tilki D, Svatek RS, Karakiewicz PI et al (2010) pT3 substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. J Urol 184:470–474
Skinner DG (1980) Current perspectives in the management of high-grade invasive bladder cancer. Cancer 45:1866–1874
Dalbagni G, Genega E, Hashibe M et al (2001) Cystectomy for bladder cancer: a contemporary series. J Urol 165:1111–1116
Quek ML, Stein JP, Clark PE et al (2004) Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol 171:640–645
Scosyrev E, Yao J, Messing E (2010) Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice. Urology 76(4):908–913
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dincel, C., Kara, C., Balci, U. et al. Comparison of microscopic (pT3a) and gross extravesical extension (pT3b) in pathological staging of bladder cancer: analysis of patient outcomes. Int Urol Nephrol 45, 387–393 (2013). https://doi.org/10.1007/s11255-013-0381-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-013-0381-7